Azenta, Inc.
NASDAQ:AZTAMedical - Instruments & Supplies
-$0.03 today
- Market cap
- $2.13B
- Beta
- 1.40
- P/E (TTM)
- -5.9
- EPS (TTM)
- -$3.87
Volume 0.69M
Average 1.16M
AZTA Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Azenta, Inc.NASDAQ: AZTA
Depreciation & Amortization · Q4 FY2026 · quarter ended Sep 2026
Depreciation & amortization growth accelerates
Q4 FY2026 depreciation & amortization of $15.29M rose 5.9% year over year, ahead of the -7.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 12.6% from the prior quarter. Over 3 fiscal years it compounded at -12.9% a year.
Context
- Depreciation & amortization amounted to 9.1% of revenue in FY2026, down 1.2 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +5.9% holds above the trailing-twelve-month pace of -7.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2026
- 56.52M USD
- Year-over-year change
- -7.7%
- 4-year CAGR
- +1.3%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2026 | 2026-09-30 | 56.52M | -7.7% |
| FY2025 | 2025-09-30 | 61.21M | -32.5% |
| FY2024 | 2024-09-30 | 90.74M | +6.0% |
| FY2023 | 2023-09-30 | 85.58M | +59.4% |
| FY2022 | 2022-09-30 | 53.7M | — |
Depreciation & Amortization vs competitors
How AZTA compares with its peers on the latest reported figures
- AZTA's LTM Sep 2026 depreciation & amortization of $56.52M is the 8th largest of the 10 companies compared; the peer median is $127.6M.
- Its year-over-year change of -7.7% is the 5th highest of 10, against a peer median of -8.8%.
- Depreciation & amortization amounts to 9.1% of revenue for AZTA, versus a peer median of 6.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.11B | +11.2% | -6.3% | 6.6% | |
| LTM Sep 2026 | $1.91B | -21.1% | +4.7% | 7.5% | |
| LTM Jun 2026 | $506M | -5.2% | -5.4% | 6.1% | |
| LTM Jun 2026 | $230.1M | +9.4% | +35.4% | 6.6% | |
| LTM Jun 2026 | $127.6M | -23.5% | +6.4% | 4.9% | |
| LTM Aug 2026 | $117.65M | -5.8% | +8.7% | 13.3% | |
| LTM Sep 2026 | $96.75M | -8.8% | -3.2% | 7.9% | |
| LTM Sep 2026 | $56.52M | -7.7% | -12.9% | 9.1% | |
| LTM Mar 2026 | $4M | -48.5% | -34.2% | 4.0% | |
| LTM Mar 2026 | $0 | -100.0% | -11.1% | 0.0% | |
| Peer median (excluding AZTA) | $127.6M | -8.8% | -3.2% | 6.6% | |
Competitors are the stored peer set for AZTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 | FY2026 Sep 2026 |
|---|---|---|---|---|---|
| Net Income | 2.13B | (14.64M) | (164.9M) | (55.76M) | (166.99M) |
| Depreciation & Amortization | 53.7M | 85.58M | 90.74M | 61.21M | 56.52M |
| Deferred Income Tax | 24.47M | (28.74M) | (15.89M) | (27.04M) | (5.17M) |
| Stock-Based Compensation | 10.67M | 9.38M | 14.47M | 20.88M | 12.24M |
| Change in Working Capital | (72.73M) | (29.04M) | 3.04M | (22.84M) | 4.06M |
| Accounts Receivables | (31.4M) | 34.46M | (12.07M) | (24.56M) | 4.42M |
| Inventory | (66.63M) | 8.25M | 15.9M | (2.67M) | (8.04M) |
| Accounts Payables | (3.93M) | (14.71M) | 9.2M | 1.04M | 12.66M |
| Other Working Capital | 29.22M | (57.04M) | (9.99M) | 3.36M | (4.99M) |
| Other Non-Cash Items | (2.62B) | (16.71M) | 122.28M | 95.73M | 156.84M |
| Operating Cash Flow | (466.05M) | 5.83M | 49.74M | 72.18M | 57.51M |
| Capital Expenditures | (77.44M) | (39.44M) | (37.39M) | (33.86M) | (30.08M) |
| Acquisitions (Net) | 2.81B | (386.51M) | 0 | 0 | (11.15M) |
| Purchases of Investments | (1.98B) | (236.19M) | (405.58M) | (451.41M) | (375.68M) |
| Sales of Investments | 705.38M | 1.09B | 667.71M | 394.81M | 328.61M |
| Other Investing Activities | (4M) | 0 | 0 | 0 | 54.5M |
| Investing Cash Flow | 1.47B | 431.38M | 224.74M | (90.46M) | (33.8M) |
| Debt Repayment | (50.11M) | (578K) | (783K) | (985K) | (748K) |
| Common Stock Issued | 5.25M | 3.62M | 3.28M | 2.77M | 2.2M |
| Common Stock Repurchased | 0 | (838.51M) | (661.7M) | 0 | (118.29M) |
| Dividends Paid | (7.49M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (10.4M) | (4.99M) | 0 | (11.38M) | (2.67M) |
| Financing Cash Flow | (62.76M) | (840.46M) | (659.21M) | (9.59M) | (119.5M) |
| Effect of Forex Changes | (180.82M) | 45.99M | 21.67M | 3.57M | (2.58M) |
| Net Change in Cash | 755.96M | (357.25M) | (363.06M) | (24.31M) | (98.37M) |
| Free Cash Flow | (543.48M) | (33.6M) | 12.35M | 38.32M | 27.43M |
Azenta, Inc.
NASDAQ:AZTA
Intrinsic Alpha fair value
Locked
Current Price
$48.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.